Published in J Virol on April 11, 2007
Bayesian phylogeography finds its roots. PLoS Comput Biol (2009) 10.99
Regional Isolation Drives Bacterial Diversification within Cystic Fibrosis Lungs. Cell Host Microbe (2015) 2.98
Analysis of human immunodeficiency virus type 1 viremia and provirus in resting CD4+ T cells reveals a novel source of residual viremia in patients on antiretroviral therapy. J Virol (2009) 1.89
The HIV-1 reservoir in eight patients on long-term suppressive antiretroviral therapy is stable with few genetic changes over time. Proc Natl Acad Sci U S A (2013) 1.80
Three roads diverged? Routes to phylogeographic inference. Trends Ecol Evol (2010) 1.74
HIV-1 Populations in Semen Arise through Multiple Mechanisms. PLoS Pathog (2010) 1.47
Single cell analysis of lymph node tissue from HIV-1 infected patients reveals that the majority of CD4+ T-cells contain one HIV-1 DNA molecule. PLoS Pathog (2013) 1.31
Role of donor genital tract HIV-1 diversity in the transmission bottleneck. Proc Natl Acad Sci U S A (2011) 1.30
Origin and evolution of HIV-1 in breast milk determined by single-genome amplification and sequencing. J Virol (2010) 1.26
Deep molecular characterization of HIV-1 dynamics under suppressive HAART. PLoS Pathog (2011) 1.21
Low-level plasma HIVs in patients on prolonged suppressive highly active antiretroviral therapy are produced mostly by cells other than CD4 T-cells. J Med Virol (2009) 1.19
Restriction of HIV-1 genotypes in breast milk does not account for the population transmission genetic bottleneck that occurs following transmission. PLoS One (2010) 1.13
Modelling tree shape and structure in viral phylodynamics. Philos Trans R Soc Lond B Biol Sci (2013) 1.12
Compartmentalization of HIV-1 within the female genital tract is due to monotypic and low-diversity variants not distinct viral populations. PLoS One (2009) 1.11
Editorial neuroAIDS review. AIDS (2011) 1.10
Toward a quantitative understanding of viral phylogeography. Curr Opin Virol (2011) 1.10
Evidence for limited genetic compartmentalization of HIV-1 between lung and blood. PLoS One (2009) 1.09
Human immunodeficiency virus-1 evolutionary patterns associated with pathogenic processes in the brain. J Neurovirol (2010) 1.07
Compartmentalized replication of R5 T cell-tropic HIV-1 in the central nervous system early in the course of infection. PLoS Pathog (2015) 1.04
Genetic analyses of HIV-1 env sequences demonstrate limited compartmentalization in breast milk and suggest viral replication within the breast that increases with mastitis. J Virol (2010) 1.00
Intercompartmental recombination of HIV-1 contributes to env intrahost diversity and modulates viral tropism and sensitivity to entry inhibitors. J Virol (2011) 1.00
Differing patterns of selection and geospatial genetic diversity within two leading Plasmodium vivax candidate vaccine antigens. PLoS Negl Trop Dis (2014) 0.96
Human immunodeficiency viruses appear compartmentalized to the female genital tract in cross-sectional analyses but genital lineages do not persist over time. J Infect Dis (2013) 0.91
Genital tract sequestration of SIV following acute infection. PLoS Pathog (2011) 0.90
Different regions of HIV-1 subtype C env are associated with placental localization and in utero mother-to-child transmission. J Virol (2011) 0.89
Small ruminant lentiviruses: genetic variability, tropism and diagnosis. Viruses (2013) 0.87
Reduced genetic diversity in lymphoid and central nervous system tissues and selection-induced tissue-specific compartmentalization of neuropathogenic SIVsmmFGb during acute infection. AIDS Res Hum Retroviruses (2009) 0.85
Impact of seminal cytomegalovirus replication on HIV-1 dynamics between blood and semen. J Med Virol (2012) 0.85
A machine learning approach for identifying amino acid signatures in the HIV env gene predictive of dementia. PLoS One (2012) 0.82
Molecular epigenetics, chromatin, and NeuroAIDS/HIV: translational implications. Bioinformation (2008) 0.82
HIV migration between blood and cerebrospinal fluid or semen over time. J Infect Dis (2013) 0.82
Elevated cytokine and chemokine levels in the placenta are associated with in-utero HIV-1 mother-to-child transmission. AIDS (2012) 0.81
Study of compartmentalization in the visna clinical form of small ruminant lentivirus infection in sheep. BMC Vet Res (2012) 0.81
Sexual transmission of predicted CXCR4-tropic HIV-1 likely originating from the source partner's seminal cells. Virology (2012) 0.80
Evidence of distinct populations of hepatitis C virus in the liver and plasma of patients co-infected with HIV and HCV. J Med Virol (2014) 0.78
Compartmentalized HIV rebound in the central nervous system after interruption of antiretroviral therapy. Virus Evol (2016) 0.78
HIV variability in the liver and evidence of possible compartmentalization. AIDS Res Hum Retroviruses (2011) 0.77
Analysis of a non-structural gene reveals evidence of possible hepatitis C virus (HCV) compartmentalization. J Med Virol (2012) 0.77
HIV-1 Nef sequence and functional compartmentalization in the gut is not due to differential cytotoxic T lymphocyte selective pressure. PLoS One (2013) 0.76
Analysis of Dominant HIV Quasispecies Suggests Independent Viral Evolution Within Spinal Granulomas Coinfected with Mycobacterium tuberculosis and HIV-1 Subtype C. AIDS Res Hum Retroviruses (2015) 0.75
HIV migration between blood plasma and cellular subsets before and after HIV therapy. J Med Virol (2015) 0.75
Genotypic and phenotypic heterogeneity in the U3R region of HIV type 1 subtype C. AIDS Res Hum Retroviruses (2013) 0.75
Dynamic of CSF and serum biomarkers in HIV-1 subtype C encephalitis with CNS genetic compartmentalization-case study. J Neurovirol (2017) 0.75
HIV-1 envelope accessible surface and polarity: clade, blood, and brain. Bioinformation (2011) 0.75
Insights into the impact of CD8+ immune modulation on HIV evolutionary dynamics in distinct anatomical compartments using SIV-infected macaque models of AIDS progression. J Virol (2017) 0.75
Dating of the human-ape splitting by a molecular clock of mitochondrial DNA. J Mol Evol (1985) 47.78
Analysis of molecular variance inferred from metric distances among DNA haplotypes: application to human mitochondrial DNA restriction data. Genetics (1992) 43.80
Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. N Engl J Med (2000) 41.18
Estimation of the number of nucleotide substitutions in the control region of mitochondrial DNA in humans and chimpanzees. Mol Biol Evol (1993) 38.03
Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda. J Infect Dis (2005) 21.08
HyPhy: hypothesis testing using phylogenies. Bioinformatics (2004) 17.33
Seq-Gen: an application for the Monte Carlo simulation of DNA sequence evolution along phylogenetic trees. Comput Appl Biosci (1997) 17.32
Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda. Lancet (2001) 13.32
Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy. Science (1986) 11.74
Bias, prevalence and kappa. J Clin Epidemiol (1993) 10.63
Consistent viral evolutionary changes associated with the progression of human immunodeficiency virus type 1 infection. J Virol (1999) 10.41
Estimation of levels of gene flow from DNA sequence data. Genetics (1992) 9.82
Maximum likelihood estimation of a migration matrix and effective population sizes in n subpopulations by using a coalescent approach. Proc Natl Acad Sci U S A (2001) 9.38
A statistical test for detecting geographic subdivision. Mol Biol Evol (1992) 8.79
Maximum-likelihood estimation of migration rates and effective population numbers in two populations using a coalescent approach. Genetics (1999) 8.76
Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients. Proc Natl Acad Sci U S A (1986) 8.45
Viral resistance to human immunodeficiency virus type 1-specific pyridinone reverse transcriptase inhibitors. J Virol (1991) 7.01
Sexual transmission of HIV. N Engl J Med (1997) 6.84
A cladistic measure of gene flow inferred from the phylogenies of alleles. Genetics (1989) 6.79
Automated phylogenetic detection of recombination using a genetic algorithm. Mol Biol Evol (2006) 5.94
Characterization of human immunodeficiency viruses resistant to oxathiolane-cytosine nucleosides. Antimicrob Agents Chemother (1993) 5.08
Extensive variation of human immunodeficiency virus type-1 in vivo. Nature (1988) 5.02
Quantitative image analysis of HIV-1 infection in lymphoid tissue. Science (1996) 4.72
Gender differences in HIV-1 diversity at time of infection. Nat Med (2000) 4.69
The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors. J Clin Invest (1998) 3.66
Comparison of Bayesian and maximum-likelihood inference of population genetic parameters. Bioinformatics (2005) 3.49
Genetic characterization of human immunodeficiency virus type 1 in blood and genital secretions: evidence for viral compartmentalization and selection during sexual transmission. J Virol (1996) 3.48
A new statistic for detecting genetic differentiation. Genetics (2000) 3.20
Identification of shared populations of human immunodeficiency virus type 1 infecting microglia and tissue macrophages outside the central nervous system. J Virol (2001) 2.62
SIMCOAL: a general coalescent program for the simulation of molecular data in interconnected populations with arbitrary demography. J Hered (2001) 2.45
Evolution of envelope sequences from the genital tract and peripheral blood of women infected with clade A human immunodeficiency virus type 1. J Virol (1998) 2.21
Serial SimCoal: a population genetics model for data from multiple populations and points in time. Bioinformatics (2004) 2.18
HIV in body fluids during primary HIV infection: implications for pathogenesis, treatment and public health. AIDS (2001) 2.08
Genetic and functional analysis of full-length human immunodeficiency virus type 1 env genes derived from brain and blood of patients with AIDS. J Virol (2003) 2.07
Selection of drug-resistant variants in the female genital tract of human immunodeficiency virus type 1-infected women receiving antiretroviral therapy. J Infect Dis (2000) 1.86
HIV-1 in genital tract and plasma of women: compartmentalization of viral sequences, coreceptor usage, and glycosylation. Proc Natl Acad Sci U S A (2003) 1.71
Genetic composition of human immunodeficiency virus type 1 in cerebrospinal fluid and blood without treatment and during failing antiretroviral therapy. J Virol (2005) 1.68
Increased human immunodeficiency virus type 1 (HIV-1) env compartmentalization in the presence of HIV-1-associated dementia. J Virol (2005) 1.65
Evolutionary indicators of human immunodeficiency virus type 1 reservoirs and compartments. J Virol (2003) 1.62
Genetic drift and within-host metapopulation dynamics of HIV-1 infection. Proc Natl Acad Sci U S A (2001) 1.61
Genetic attributes of cerebrospinal fluid-derived HIV-1 env. Brain (2006) 1.60
Human immunodeficiency virus type 1 genomic RNA sequences in the female genital tract and blood: compartmentalization and intrapatient recombination. J Virol (2005) 1.53
Semen-specific genetic characteristics of human immunodeficiency virus type 1 env. J Virol (2005) 1.52
Time course of cerebrospinal fluid responses to antiretroviral therapy: evidence for variable compartmentalization of infection. AIDS (1999) 1.50
Phylodynamic analysis of human immunodeficiency virus type 1 in distinct brain compartments provides a model for the neuropathogenesis of AIDS. J Virol (2005) 1.49
Cellular replication of human immunodeficiency virus type 1 occurs in vaginal secretions. J Infect Dis (2001) 1.38
Effects of genital tract inflammation on human immunodeficiency virus type 1 V3 populations in blood and semen. J Virol (2000) 1.38
Investigation of the dynamics of the spread of human immunodeficiency virus to brain and other tissues by evolutionary analysis of sequences from the p17gag and env genes. J Virol (1997) 1.32
Antiretroviral drugs and the central nervous system. AIDS (1998) 1.28
Astrocyte specific viral strains in HIV dementia. Ann Neurol (2004) 1.26
Genotypic and phenotypic characterization of HIV-1 isolated from patients receiving (--)-2',3'-dideoxy-3'-thiacytidine. Antiviral Res (1995) 1.26
Independent evolution of HIV type 1 in different brain regions. AIDS Res Hum Retroviruses (1999) 1.25
Altered P-glycoprotein expression in AIDS patients with HIV encephalitis. J Neuropathol Exp Neurol (2004) 1.21
Redistribution of HIV outside the lymphoid system with onset of AIDS. Lancet (1994) 1.14
Differences in HIV-1 pol sequences from female genital tract and blood during antiretroviral therapy. J Acquir Immune Defic Syndr (2003) 1.10
Antiretroviral resistance mutations in human immunodeficiency virus type 1 reverse transcriptase and protease from paired cerebrospinal fluid and plasma samples. J Infect Dis (2000) 1.09
Compartmentalization of HIV-1 in the central nervous system: role of the choroid plexus. AIDS (2005) 1.06
Determinants of human immunodeficiency virus type 1 resistance to membrane-anchored gp41-derived peptides. J Virol (2005) 1.06
Human immunodeficiency virus type 1 compartmentalization in the central nervous system. J Neurovirol (2004) 1.01
Neurological disorders during HIV-1 infection correlate with viral load in cerebrospinal fluid but not with virus phenotype. AIDS (1998) 0.98
Clinical implications of HIV-1 drug resistance in the neurological compartment. Scand J Infect Dis Suppl (2003) 0.92
Active HIV-1 redistribution and replication in the brain with HIV encephalitis. Arch Virol (1999) 0.89
Cell membrane proteins and quasispecies compartmentalization of CSF and plasma HIV-1 from aids patients with neurological disorders. Infect Genet Evol (2004) 0.88
HyPhy: hypothesis testing using phylogenies. Bioinformatics (2004) 17.33
Not so different after all: a comparison of methods for detecting amino acid sites under selection. Mol Biol Evol (2005) 10.21
Datamonkey: rapid detection of selective pressure on individual sites of codon alignments. Bioinformatics (2005) 8.62
Datamonkey 2010: a suite of phylogenetic analysis tools for evolutionary biology. Bioinformatics (2010) 6.14
Automated phylogenetic detection of recombination using a genetic algorithm. Mol Biol Evol (2006) 5.94
GARD: a genetic algorithm for recombination detection. Bioinformatics (2006) 4.88
Evaluation of respondent-driven sampling. Epidemiology (2012) 4.75
An evolutionary model-based algorithm for accurate phylogenetic breakpoint mapping and subtype prediction in HIV-1. PLoS Comput Biol (2009) 3.11
Persistence of transmitted drug resistance among subjects with primary human immunodeficiency virus infection. J Virol (2008) 3.04
A random effects branch-site model for detecting episodic diversifying selection. Mol Biol Evol (2011) 2.88
Characterization of human immunodeficiency virus type 1 (HIV-1) envelope variation and neutralizing antibody responses during transmission of HIV-1 subtype B. J Virol (2005) 2.83
Multiple emergences of genetically diverse amphibian-infecting chytrids include a globalized hypervirulent recombinant lineage. Proc Natl Acad Sci U S A (2011) 2.78
A genetic algorithm approach to detecting lineage-specific variation in selection pressure. Mol Biol Evol (2004) 2.65
Transmission fitness of drug-resistant human immunodeficiency virus and the prevalence of resistance in the antiretroviral-treated population. J Infect Dis (2003) 2.54
The role of macrophage/microglia and astrocytes in the pathogenesis of three neurologic disorders: HIV-associated dementia, Alzheimer disease, and multiple sclerosis. J Neurol Sci (2002) 2.53
Adaptation to different human populations by HIV-1 revealed by codon-based analyses. PLoS Comput Biol (2006) 2.48
Immune-driven recombination and loss of control after HIV superinfection. J Exp Med (2008) 2.34
Phylodynamics of infectious disease epidemics. Genetics (2009) 2.15
Syringe possession arrests are associated with receptive syringe sharing in two Mexico-US border cities. Addiction (2007) 2.14
Lack of neutralizing antibody response to HIV-1 predisposes to superinfection. Virology (2006) 2.07
Coping with viral diversity in HIV vaccine design. PLoS Comput Biol (2007) 2.01
A maximum likelihood method for detecting directional evolution in protein sequences and its application to influenza A virus. Mol Biol Evol (2008) 1.96
An evolutionary-network model reveals stratified interactions in the V3 loop of the HIV-1 envelope. PLoS Comput Biol (2007) 1.82
A public health model for the molecular surveillance of HIV transmission in San Diego, California. AIDS (2009) 1.81
Long-term persistence of transmitted HIV drug resistance in male genital tract secretions: implications for secondary transmission. J Infect Dis (2007) 1.64
Evolutionary fingerprinting of genes. Mol Biol Evol (2009) 1.64
Genetic attributes of cerebrospinal fluid-derived HIV-1 env. Brain (2006) 1.60
Herpes simplex virus type 2 infection does not influence viral dynamics during early HIV-1 infection. J Infect Dis (2007) 1.59
Simple epidemiological dynamics explain phylogenetic clustering of HIV from patients with recent infection. PLoS Comput Biol (2012) 1.51
A Dirichlet process model for detecting positive selection in protein-coding DNA sequences. Proc Natl Acad Sci U S A (2006) 1.47
A simple hierarchical approach to modeling distributions of substitution rates. Mol Biol Evol (2004) 1.42
Spidermonkey: rapid detection of co-evolving sites using Bayesian graphical models. Bioinformatics (2008) 1.40
Using respondent-driven sampling in a hidden population at risk of HIV infection: who do HIV-positive recruiters recruit? Sex Transm Dis (2009) 1.37
Phylogenetic analysis of population-based and deep sequencing data to identify coevolving sites in the nef gene of HIV-1. Mol Biol Evol (2009) 1.37
Individual and network factors associated with prevalent hepatitis C infection among rural Appalachian injection drug users. Am J Public Health (2012) 1.35
Respondent driven sampling--where we are and where should we be going? Sex Transm Infect (2012) 1.35
Adaptation to human populations is revealed by within-host polymorphisms in HIV-1 and hepatitis C virus. PLoS Pathog (2007) 1.31
Amprenavir-resistant HIV-1 exhibits lopinavir cross-resistance and reduced replication capacity. AIDS (2002) 1.28
Evolutionary interactions between N-linked glycosylation sites in the HIV-1 envelope. PLoS Comput Biol (2006) 1.25
Viral evolution during structured treatment interruptions in chronically human immunodeficiency virus-infected individuals. J Virol (2002) 1.24
Deep molecular characterization of HIV-1 dynamics under suppressive HAART. PLoS Pathog (2011) 1.21
Low-level plasma HIVs in patients on prolonged suppressive highly active antiretroviral therapy are produced mostly by cells other than CD4 T-cells. J Med Virol (2009) 1.19
Evaluation of the role of location and distance in recruitment in respondent-driven sampling. Int J Health Geogr (2011) 1.14
Beyond bushmeat: animal contact, injury, and zoonotic disease risk in Western Uganda. Ecohealth (2014) 1.13
Capture-recapture methods and respondent-driven sampling: their potential and limitations. Sex Transm Infect (2011) 1.13
Selection of drug-resistant HIV-1 mutants in response to repeated structured treatment interruptions. AIDS (2002) 1.12
Evolution of the interferon alpha gene family in eutherian mammals. Gene (2007) 1.12
Editorial neuroAIDS review. AIDS (2011) 1.10
Clinical, virologic, and immunologic correlates of HIV-1 intraclade B dual infection among men who have sex with men. AIDS (2012) 1.10
Increased density of neurons containing NADPH diaphorase and nitric oxide synthase in the cerebral cortex of patients with HIV-1 infection and drug abuse. J NeuroAIDS (2002) 1.08
Using phylogeography to characterize the origins of the HIV-1 subtype F epidemic in Romania. Infect Genet Evol (2011) 1.07
Epidemiological bridging by injection drug use drives an early HIV epidemic. Epidemics (2010) 1.07
HIV-1 clade B pol evolution following primary infection. PLoS One (2013) 1.07
NeuroAIDS: characteristics and diagnosis of the neurological complications of AIDS. Mol Diagn Ther (2008) 1.05
Phenotypic hypersusceptibility to multiple protease inhibitors and low replicative capacity in patients who are chronically infected with human immunodeficiency virus type 1. J Virol (2005) 1.05
Older age and plasma viral load in HIV-1 infection. AIDS (2004) 1.04
Parsing social network survey data from hidden populations using stochastic context-free grammars. PLoS One (2009) 1.04
Gene network effects on brain microstructure and intellectual performance identified in 472 twins. J Neurosci (2012) 1.04
Detecting signatures of selection from DNA sequences using Datamonkey. Methods Mol Biol (2009) 1.01
Detection in 2009 of the swine origin influenza A (H1N1) virus by a subtyping microarray. J Clin Microbiol (2009) 1.00
Transmitted drug resistance in the CFAR network of integrated clinical systems cohort: prevalence and effects on pre-therapy CD4 and viral load. PLoS One (2011) 0.99
Evolutionary model selection with a genetic algorithm: a case study using stem RNA. Mol Biol Evol (2006) 0.97
Characteristics of recently HIV-infected men who use the Internet to find male sex partners and sexual practices with those partners. J Acquir Immune Defic Syndr (2006) 0.97
A report on single exon genes (SEG) in eukaryotes. Front Biosci (2004) 0.96
Pleocytosis is associated with disruption of HIV compartmentalization between blood and cerebral spinal fluid viral populations. Virology (2008) 0.94
Mixed adjuvant formulations reveal a new combination that elicit antibody response comparable to Freund's adjuvants. PLoS One (2012) 0.93
Genetic basis of hypersusceptibility to protease inhibitors and low replicative capacity of human immunodeficiency virus type 1 strains in primary infection. J Virol (2004) 0.93
CCL3 genotype and current depression increase risk of HIV-associated dementia. Neurobehav HIV Med (2009) 0.93
Respondent driven sampling: determinants of recruitment and a method to improve point estimation. PLoS One (2013) 0.93
A framework to sub-type HLA supertypes. Front Biosci (2005) 0.93
Rapid social network assessment for predicting HIV and STI risk among men attending bars and clubs in San Diego, California. Sex Transm Infect (2010) 0.91
The role of host genetics in the susceptibility for HIV-associated neurocognitive disorders. AIDS Behav (2008) 0.91
Osteoimmunopathology in HIV/AIDS: A Translational Evidence-Based Perspective. Patholog Res Int (2011) 0.89
Computational prediction of SEG (single exon gene) function in humans. Front Biosci (2005) 0.89
Functional polymorphisms in dopamine-related genes: effect on neurocognitive functioning in HIV+ adults. J Clin Exp Neuropsychol (2011) 0.88
Crack cocaine: effect modifier of RNA viral load and CD4 count in HIV infected African American women. Front Biosci (2007) 0.88
Sampling through time and phylodynamic inference with coalescent and birth-death models. J R Soc Interface (2014) 0.88
Can non-lytic CD8+ T cells drive HIV-1 escape? PLoS Pathog (2013) 0.87
Herpes simplex virus type 2 acquisition during recent HIV infection does not influence plasma HIV levels. J Acquir Immune Defic Syndr (2008) 0.86
Presenilin-1 detection in brain neurons and FOXP3 in peripheral blood mononuclear cells: normalizer gene selection for real time reverse transcriptase pcr using the deltadeltaCt method. Front Biosci (2005) 0.86
HIV-associated dementia, Alzheimer's disease, multiple sclerosis, and schizophrenia: gene expression review. J Neurol Sci (2004) 0.86
Detection of HIV-1 in injection paraphernalia: risk in an era of heightened awareness. AIDS Patient Care STDS (2006) 0.86
Systems analysis of human brain gene expression: mechanisms for HIV-associated neurocognitive impairment and common pathways with Alzheimer's disease. BMC Med Genomics (2013) 0.86
Computational analysis and identification of amino acid sites in dengue E proteins relevant to development of diagnostics and vaccines. Virus Genes (2007) 0.86
Mapping protease inhibitor resistance to human immunodeficiency virus type 1 sequence polymorphisms within patients. J Virol (2007) 0.85
The prevalence of human immunodeficiency virus type 1 and hepatitis C virus among injection drug users who use high risk inner-city locales in Miami, Florida. Mem Inst Oswaldo Cruz (2005) 0.85
Human immunodeficiency virus-1 RNA levels in cerebrospinal fluid exhibit a set point in clinically stable patients not receiving antiretroviral therapy. J Infect Dis (2003) 0.85
Impaired cytokine production and suppressed lymphocyte proliferation activity in HCV-infected cocaine and heroin ("speedball") users. Drug Alcohol Depend (2006) 0.84
Genome-wide association study of neurocognitive impairment and dementia in HIV-infected adults. Am J Med Genet B Neuropsychiatr Genet (2012) 0.84
Paradigm development: comparative and predictive 3D modeling of HIV-1 Virion Infectivity Factor (Vif). Bioinformation (2006) 0.83
Genomic characterization of two novel HIV-1 second-generation recombinant forms among men who have sex with men in Beijing, China. AIDS Res Hum Retroviruses (2015) 0.82
Transcriptome analysis of HIV-infected peripheral blood monocytes: gene transcripts and networks associated with neurocognitive functioning. J Neuroimmunol (2013) 0.82
Molecular epigenetics, chromatin, and NeuroAIDS/HIV: immunopathological implications. Bioinformation (2008) 0.81